This opinion cited by 49 cases:
Tokyo Keiso Co., Ltd. v. SMC Corp. , 533 F. Supp. 2d 1047 ( 2007 )
Ulead Systems, Inc. v. Lex Computer & Management Corp. , 151 F. Supp. 2d 1192 ( 2001 )
Altana Pharma AG v. Teva Pharmaceuticals USA, Inc. , 566 F.3d 999 ( 2009 )
Cartner v. Alamo Group, Inc. , 561 F. App'x 958 ( 2014 )
Teleflex, Inc. v. Ficosa North America Corp., Fico Cables, S.A., and Ficosa North America S.A. De C.V. , 299 F.3d 1313 ( 2002 )
Takeda Chemical Industries, Ltd. v. Mylan Laboratories, Inc. , 549 F.3d 1381 ( 2008 )
Eli Lilly & Co. v. Zenith Goldline Pharmaceuticals, Inc. , 471 F.3d 1369 ( 2006 )
Monolithic Power Systems, Inc. v. O2 Micro International Ltd. ( 2013 )
Glaxo Group Limited and Smithkline Beecham Corp. v. Apotex, Inc. , 376 F.3d 1339 ( 2004 )
Minnesota Mining and Manufacturing Company and Riker Laboratories, Inc., and Alphapharm Pty. Ltd., Intervenor-Appellant v. Barr Laboratories, Inc. , 295 F.3d 1274 ( 2002 )
Amgen Inc., Plaintiff-Cross v. Hoechst Marion Roussel, Inc. (Now Known as Aventis Pharmaceuticals, Inc.) and Transkaryotic Therapies, Inc. , 314 F.3d 1313 ( 2003 )
AstraZeneca UK Ltd. v. Aurobindo Pharma Ltd. , 703 F.3d 511 ( 2012 )
Randolph J. Noelle v. Seth Lederman, Leonard Chess, and Michael J. Yellin , 355 F.3d 1343 ( 2004 )
OTSUKA PHARMACEUTICAL CO., LTD. v. Sandoz, Inc. , 678 F.3d 1280 ( 2012 )
Eli Lilly & Co. v. Zenith Goldline Pharmaceuticals, Inc. , 364 F. Supp. 2d 820 ( 2005 )
Icon Health & Fitness v. Octane Fitness , 576 F. App'x 1002 ( 2014 )
Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, Inc , 769 F.3d 1339 ( 2014 )
Alcon Research, Ltd. v. Apotex Inc. , 790 F. Supp. 2d 868 ( 2011 )
Merck & Co. v. Teva Pharmaceuticals USA, Inc. , 228 F. Supp. 2d 480 ( 2002 )
Bristol-Myers Squibb Co. v. Andrx Pharmaceuticals, Inc. , 343 F. Supp. 2d 1124 ( 2004 )
